Abstract:Objective: To develop an MR optical dual-modality probe targeting angiogenesis of gastric; cancer and to study its physical characteristics, in vitro cytotoxicity and magnetic effects of different pulse sequences on 3 T clinical MR scanner. Methods: We conjugated GXl-Cy5.5, a novel gastric cancer neo-vasculature targeted peptide labeled with Cy5.5, to the surface functionalized magnetic: nanoparticles according to different molecular weights (1:100, 1:500), resulting in dual-modality probe DPs, and DPs (named DPs). The hydrodynamic size and zeta potential of DPs and DPs were analyzed by nano-ZS. The human umbilical vein endothelial cells (HUVECs) and BGC-823 cells were treated with DPs for 24 h, and methyl thiazol tetrazolium (MTT) method was used to detect the survival rate of cells. DPs with different concentrations were scanned on different MR sequences, and then the relative signal intensity was observed. The absorbance of HUVECs and BGC823 cells treated with DPs of different concentration (0.00, 1.25, 2.50, 15.00, 50.00, 100.00 and 150.00 (xg/ml) were compared with single factor analysis of variance. Relative signal intensity of different MR sequences was compared using a paired Wilcoxon signed-rank test. Results: The dual-modality probe targeting angiogenesis of gastric cancer was successfully constructed. The hydrodynamic size of iron oxide nanoparticles, DPs and DPswas (35.23±0.07), (39.49±0.16) and (40.43±1.70) nm and the Zeta potential was (0.31±0.20), (-4.15±0.79) and (-10.51±2.37) mV. The coupled rates of DPs and DPs with polypeptide were 92% and 94% respectively. The absorbance of HUVECs and BGC823 cells treated with DPs of different concentrations were 0.76±0.04, 0.80±0.03, 0.79±0.05, 0.75±0.06, 0.74±0.05, 0.77±0.01, 0.71±0.04 and 0.38±0.04, 0.43±0.04, 0.41±0.03, 0.43±0.07, 0.44±0.04, 0.41±0.07 and 0.40±0.04, there was no statistical significance (F=0.94, 0.51; P≤0.05). The signal intensity increased first and then decreased following the increasing concentrations of DPs on TWI, especially on FSPGR TWI (Z=-3.294, P 10 μg/ml, the signal intensity on SSFSE TWI was significantly decreased compared to FSE TWI (Z=-2.023, P<0.05). Conclusions: DPs may be potential dual-modal probes for characterization of tumor angiogenesis by MR and optical imaging noninvasively, without causing significant effects on the cell activity in vitro, and SSFSE TWI may be the most sensitive sequence for DPs evaluation on MR.

Preparation of Molecular Probe Modified by Non RGD Peptide and Its Targeting Effect on Human Umbilical Vein Endothelial Cells

Preparation of Non RGD Peptide Conjugated Ultrasmall Superparamagnetic Iron Particles and Its Targeting Effect on Human Umbilical Vein Endothelial Cells

Novel Peptide Targeting Integrin Αvβ3‐rich Tumor Cells by Magnetic Resonance Imaging

Preparation of MR Molecular Probe Targeting Integrin Αvβ3 Receptor and Its in Vitro Imaging

Construction of cRGD-iron oxide nanoparticles and its application in the tumor diagnosis by magnetic resonance imaging

Magnetic Resonance Imaging Contrast Agent: Crgd-Ferric Oxide Nanometer Particle and Its Role in the Diagnosis of Tumor

Preparation of MR Molecular Probes Targeting CD40 Mutant and the Preliminary Study of Imaging Ovarian Cancer in Vitro

Magnetic resonance signal detection of superparamagnetic iron oxide nanoparticles and its biological effects on endothelial cells]

Preparation and Evaluation of Neovessel-targeted Paramagnetic PEGylated Liposome

Fabrication of Molecular Probe Targeting NRP-1 and Magnetic Resonance Molecular Imaging of Gliomas in Vitro

Modification of MR Molecular Imaging Probes with Cysteine-Terminated Peptides and Their Potential for in Vivo Tumour Detection.

Preparation and characterization of peptide modified ultrasmall superparamagnetic iron oxides used as tumor targeting MRI contrast agent

A GPC3-specific aptamer-mediated magnetic resonance probe for hepatocellular carcinoma.

Preparation of VEGFR-2-loaded superparamagnetic iron oxide nanoprobes and MRI molecular imaging with liver cancer cells

Synthesis of a Novel Long-Circulating Dual-Receptor Targeting and Dual-Modal Molecular Probe：an In-Vitro Study

Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner.

Preparation of MRI molecular probe targeting human epidermal growth factor receptor 2 and the ;preliminary study of breast cancer cell in vitro

Preliminary Study of Breast Cancer Magnetic Resonance Targeting Diagnosis Basing on Magnetic Nanoparticles in Vitro

99mTc-Labeled Iron Oxide Nanoparticles for Dual-Contrast ( T 1 / T 2 ) Magnetic Resonance and Dual-Modality Imaging of Tumor Angiogenesis

Preparation and characterization of dual-modality molecular probes for imaging angiogenesis of gastric cancer

Specific Targeting of Angiogenesis in Lung Cancer with RGD-conjugated Ultrasmall Superparamagnetic Iron Oxide Particles Using a 4.7T Magnetic Resonance Scanner.